[DPHARMA] YoY Quarter Result on 30-Jun-2014 [#2]

Stock
[DPHARMA] DUOPHARMA BIOTECH BERHAD
Announcement Date
26-Aug-2014
Admission Sponsor
-
Sponsor
-
Financial Year
31-Dec-2014
Quarter
30-Jun-2014 [#2]
Profit Trend
QoQ- -10.19%
YoY- -29.71%
Quarter Report
Latest QR
Upcoming QR
DPHARMA's Result
DPHARMA's Financial Summary
View:
Show?
Quarter Result
30/06/17 30/06/16 30/06/15 30/06/14 30/06/13 30/06/12 30/06/11 CAGR
Revenue 117,049 79,135 56,308 40,623 37,988 34,355 35,345 22.06%
PBT 12,642 7,723 8,407 10,107 13,007 9,037 9,292 5.26%
Tax -3,001 -3,782 -2,559 -2,594 -2,318 -2,170 -2,360 4.08%
NP 9,641 3,941 5,848 7,513 10,689 6,867 6,932 5.64%
-
NP to SH 9,653 4,503 5,848 7,513 10,689 6,867 6,932 5.66%
-
Tax Rate 23.74% 48.97% 30.44% 25.67% 17.82% 24.01% 25.40% -
Total Cost 107,408 75,194 50,460 33,110 27,299 27,488 28,413 24.78%
-
Net Worth 463,071 446,334 189,815 179,145 187,404 162,310 154,198 20.09%
Dividend
30/06/17 30/06/16 30/06/15 30/06/14 30/06/13 30/06/12 30/06/11 CAGR
Div 6,973 6,973 5,582 5,554 5,552 4,855 4,862 6.18%
Div Payout % 72.25% 154.87% 95.47% 73.94% 51.95% 70.71% 70.14% -
Equity
30/06/17 30/06/16 30/06/15 30/06/14 30/06/13 30/06/12 30/06/11 CAGR
Net Worth 463,071 446,334 189,815 179,145 187,404 162,310 154,198 20.09%
NOSH 278,959 278,959 139,570 138,872 138,818 138,727 138,917 12.30%
Ratio Analysis
30/06/17 30/06/16 30/06/15 30/06/14 30/06/13 30/06/12 30/06/11 CAGR
NP Margin 8.24% 4.98% 10.39% 18.49% 28.14% 19.99% 19.61% -
ROE 2.08% 1.01% 3.08% 4.19% 5.70% 4.23% 4.50% -
Per Share
30/06/17 30/06/16 30/06/15 30/06/14 30/06/13 30/06/12 30/06/11 CAGR
RPS 41.96 28.37 40.34 29.25 27.37 24.76 25.44 8.68%
EPS 3.46 1.41 4.19 5.41 7.70 4.95 4.99 -5.91%
DPS 2.50 2.50 4.00 4.00 4.00 3.50 3.50 -5.44%
NAPS 1.66 1.60 1.36 1.29 1.35 1.17 1.11 6.93%
Adjusted Per Share Value based on latest NOSH - 138,872
30/06/17 30/06/16 30/06/15 30/06/14 30/06/13 30/06/12 30/06/11 CAGR
RPS 12.17 8.23 5.85 4.22 3.95 3.57 3.67 22.09%
EPS 1.00 0.47 0.61 0.78 1.11 0.71 0.72 5.62%
DPS 0.72 0.72 0.58 0.58 0.58 0.50 0.51 5.91%
NAPS 0.4814 0.464 0.1973 0.1862 0.1948 0.1687 0.1603 20.09%
Price Multiplier on Financial Quarter End Date
30/06/17 30/06/16 30/06/15 30/06/14 30/06/13 30/06/12 30/06/11 CAGR
Date 30/06/17 30/06/16 30/06/15 30/06/14 28/06/13 29/06/12 30/06/11 -
Price 2.25 2.04 2.65 2.97 2.38 2.23 2.34 -
P/RPS 5.36 7.19 6.57 10.15 8.70 9.00 9.20 -8.60%
P/EPS 65.02 126.38 63.25 54.90 30.91 45.05 46.89 5.59%
EY 1.54 0.79 1.58 1.82 3.24 2.22 2.13 -5.25%
DY 1.11 1.23 1.51 1.35 1.68 1.57 1.50 -4.89%
P/NAPS 1.36 1.28 1.95 2.30 1.76 1.91 2.11 -7.05%
Price Multiplier on Announcement Date
30/06/17 30/06/16 30/06/15 30/06/14 30/06/13 30/06/12 30/06/11 CAGR
Date 25/08/17 22/08/16 25/08/15 26/08/14 28/08/13 16/08/12 18/08/11 -
Price 2.03 2.14 2.40 3.37 2.44 2.38 2.22 -
P/RPS 4.84 7.54 5.95 11.52 8.92 9.61 8.73 -9.35%
P/EPS 58.66 132.57 57.28 62.29 31.69 48.08 44.49 4.71%
EY 1.70 0.75 1.75 1.61 3.16 2.08 2.25 -4.56%
DY 1.23 1.17 1.67 1.19 1.64 1.47 1.58 -4.08%
P/NAPS 1.22 1.34 1.76 2.61 1.81 2.03 2.00 -7.90%

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.

NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ ⃤ & YoY ⃤ figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment